SAUDI ARABIA – Lunit, a deep learning-based medical artificial intelligence (AI) company, has extended its presence in the Middle East through a new partnership with Dr. Sulaiman Al Habib Medical Group (HMG).
Under the new supply contract, Lunit will supply its AI solution for mammography analysis, Lunit INSIGHT MMG, to Dr. Sulaiman Al Habib Medical Group for the next three years
Lunit is one of the leading providers of artificial intelligence-powered solutions for cancer diagnostics and therapeutics.
After receiving FDA clearance and the CE Mark, the company’s flagship Lunit INSIGHT suite is clinically used in approximately 2,000 hospitals and medical institutions across 40+ countries.
In a press release, Brandon Suh, Chief Executive Officer of Lunit, said: “We are delighted to bring our AI-powered cancer solutions to Saudi Arabian patients through Dr. Sulaiman Al Habib Medical Group.”
Over the next three years, Dr. Sulaiman Al Habib Medical Group will deploy Lunit’s AI solution for mammography analysis across its facilities in the Kingdom of Saudi Arabia and the wider Middle East region.
HMG is the largest provider of comprehensive healthcare services in the Middle East, with 20 medical sites spread across the Kingdom of Saudi Arabia, the United Arab Emirates, and the Kingdom of Bahrain.
HMG intends to integrate Lunit INSIGHT MMG into the diagnosis systems of medical institutions across the Middle East, analyzing hundreds of thousands of mammography images annually.
“Our goal is to enhance cancer diagnosis and treatment outcomes by further providing innovative AI-powered solutions to healthcare providers throughout the Middle East,” underscored Brandon Suh.
Lunit is devoted to developing advanced medical image analytics and AI-based biomarkers via cutting-edge technology.
Additionally, Lunit is gearing up to introduce Lunit INSIGHT DBT, an AI-powered 3D Breast Tomosynthesis analysis solution, to HMG before the end of 2023.
Dr. Sulaiman Al Habib Medical Group is well suited to roll out Lunit’s AI solution for innovative breast screening for patients in the Kingdom of Saudi Arabia.
This collaboration aims to further optimize Lunit’s offerings and provide an even more advanced and seamless experience for the Kingdom of Saudi Arabia
Commenting on the significance of this collaboration, Brandon Suh stated: “The partnership holds tremendous potential for Lunit as the healthcare transformation in the Middle East is on the rise and gathers momentum.”
The advanced capabilities of Lunit INSIGHT DBT will provide more precise diagnostics compared to traditional 2D breast imaging, contributing to early detection and improved treatment outcomes.
Moreover, Lunit has entered into a new strategic pact with Cloud Solutions, a subsidiary of Dr. Sulaiman Al Habib Medical Group.
These new agreements mark a major milestone in the strategic objectives of the South Korean provider to aggressively expand its foothold across the Middle East.
In her address, Dr. Fatina Al Tahan, a Senior Consultant at Dr. Sulaiman Al Habib Medical Group, said: “We are thrilled to announce our partnership with Lunit, marking the first AI-based healthcare service available in the Kingdom of Saudi Arabia.”
Lunit and Cloud Solutions will collaborate to enhance Lunit’s AI-powered solutions based on Cloud Solution’s cutting-edge cloud AI platform.
The subsidiary of Dr. Sulaiman Al Habib Medical Group has been selected as the first beneficiary to deploy Lunit’s AI-powered solutions based on Cloud Solution’s cutting-edge cloud AI platform.
The agreement between Lunit and Cloud Solutions is set to deliver high-quality medical services to patients across the Kingdom of Saudi Arabia.
Over the next three years, Lunit and HMG will work closely to cater to the demands of patients in the region, including addressing doctor shortages and deploying AI-powered solutions to medically underserved populations.
“Breast cancer represents the most common cancer in the Saudi Arabia population in general. With Lunit’s AI solution, we expect significant innovation in healthcare services and improved patient outcomes with early detection of breast cancer,” underscored Dr. Fatina Al Tahan.
This deal comes shortly after the South Korean medical AI company entered into a collaboration agreement with Seha Virtual Hospital.
It is a timely engagement as the medical imaging market in the Middle East, which surpassed US$20 billion in 2021, is projected to exceed US$30 billion by 2029, with an expected CAGR of 5.5% from 2022 to 2029.
With the Kingdom of Saudi Arabia accounting for 52.3% of the share in the Gulf Cooperation Council, this collaboration holds immense potential for Lunit’s expansion and impact in the region.
Ultimately, the new partnership will contribute to the Kingdom’s national cancer screening program, building on the success and impact of Lunit’s collaboration with Seha Virtual Hospital.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
